Actively Recruiting

Age: 0Days - 15Years
All Genders
NCT07255469

Metabolic Fluid Responsiveness in Children

Led by University Hospital, Bordeaux · Updated on 2025-12-01

110

Participants Needed

8

Research Sites

108 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The investigators aim to validate markers of metabolic fluid-responsiveness in children with acute circulatory failure following cardiac surgery. This would allow physicians to identify which patient could benefit the most from fluid expansion, thus avoiding useless and potentially dangerous fluid expansions that could lead to fluid overload. To this end, The investigators will evaluate the diagnostic accuracy of the ratio of central venous to arterial carbon dioxide tension (Pv-aCO2) to arteriovenous oxygen content (CavO2), a simple biological marker of anaerobic metabolism, for the diagnosis of metabolic fluid responsiveness defined as a significant increase in oxygen consumption (VO2) after fluid expansion.

CONDITIONS

Official Title

Metabolic Fluid Responsiveness in Children

Who Can Participate

Age: 0Days - 15Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age less than or equal to 15 years old
  • Hospitalization in a pediatric intensive care unit after cardiac surgery
  • Prescription by the attending physician of a fluid expansion of 10ml/kg
  • Prescription of arterial and venous blood gas before and after the volume expansion to help manage acute circulatory failure
  • Patient implanted with a functioning arterial line
  • Patient implanted with a functioning central venous line in the superior vena cava territory
Not Eligible

You will not qualify if you...

  • Patient less than 37 weeks' corrected gestational age
  • Hemodynamic instability making the delay necessary for any test dangerous
  • Supine position contraindicated or deleterious
  • Impairment of echocardiographic acoustic window or restless patient making ultrasonography impossible
  • Opposition to participate expressed by the patient or by a parent or legal guardian

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 8 locations

1

Hôpital Louis Pradel - Hospices Civils de Lyon

Bron, France, France, 69500

Actively Recruiting

2

Hôpital Jeanne de Flandre - CHU de Lille

Lille, France, France, 59000

Actively Recruiting

3

Hôpital de la Timone - Assistance Publique - Hôpitaux de Marseille

Marseille, France, France, 13385

Not Yet Recruiting

4

Hôpital mère-enfant - CHU de Nantes

Nantes, France, France, 44093

Actively Recruiting

5

Hôpital Necker-Enfants Malades - Assistance Publique - Hôpitaux de Paris

Paris, France, France, 75015

Actively Recruiting

6

Hôpital Cardiologique Haut Lévêque - CHU de Bordeaux

Pessac, France, France, 33604

Actively Recruiting

7

Hôpital des enfants - CHU de Toulouse

Toulouse, France, France, 31300

Not Yet Recruiting

8

Hôpital Felix Guyon - CHU de la Réunion

Saint-Denis, La Réunion, France, 97400

Actively Recruiting

Loading map...

Research Team

J

Julin GOTCHAC, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here